Evidence map›Paper›PMID 28394361›Full record

Trial reportNutrition & diabetes2017

Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial.

M J Zibaeenezhad, P Farhadi, A Attar, A Mosleh, F Amirmoezi, A Azimi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition & diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. African walnut (Frontiers in nutrition · 2025
    Article
  14. Nutritional Advantages of Walnut (Food science & nutrition · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. African walnut (Frontiers in nutrition · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M J ZibaeenezhadCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
P FarhadiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
A AttarCardiovascular Research Center, TAHA Clinical Trial Group, Mohammad Rasool Allah Research Tower, Shiraz University of Medical Sciences, Shiraz, Iran.
A MoslehCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
F AmirmoeziCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
A AzimiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of herbal medicine is now well documented in preventing and controlling diabetes mellitus. The main aim of this study was to evaluate the effects of walnut oil consumption on lipid profiles of hyperlipidemic patients with type 2 diabetes.

methodsIn a randomized, double-blind, placebo-controlled clinical trial, 100 hyperlipidemic type 2 diabetic patients aged 35-75 years were assigned to receive 15 cc Persian walnut oil or placebo every day for 90 days. The primary outcomes were the lipid profiles.

resultsConsumption of walnut oil by type 2 hyperlipidemic diabetic patients resulted in a significant decrease in total cholesterol levels (treatment difference (TD)=-30.04, P<0.001), triglyceride (TG) level (TD=-15.04, P=0.021), low-density lipoprotein (LDL) level (TD=-30.44, P<0.001) and total cholesterol to high-density lipoprotein (HDL) ratio (TD=-0.72, P<0.001) compared to the control group. There was a trend toward increasing HDL level with consumption of walnut oil (TD=2.28, P=0.06). Frequency of patients reaching a LDL level below 100 was higher in the case group (20 vs 0%).

conclusionsAddition of walnut oil in the daily diet of type 2 diabetic patients improves lipid profiles. Thus, it may be associated with a coronary artery disease risk factor modulation. Also, walnut oil may serve as a helpful natural remedy for hyperlipidemic patients with type 2 diabetes.

Indexed as

PhytotherapyAdultAgedCholesterolCholesterol, LDLDiabetes Mellitus, Type 2Dietary Fats, UnsaturatedDouble-Blind MethodHumansHyperlipidemiasJuglansLipidsLipoproteins, HDLMiddle AgedNutsPlant OilsCholesterolCholesterol, LDLDietary Fats, UnsaturatedLipidsLipoproteins, HDLPlant OilsTriglycerides

Identifiers

PMID28394361
PMCPMC5436098
OpenAlexW2607282101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.